IPO registrations (S-1, F-1) · Registrants
CEPHEID
- SEC CIK
- 1037760 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-04-07, last 2000-06-21; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 2000-06-22
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- CA
- Business address
- 904 CARIBBEAN DRIVE, Sunnyvale, CA 94089
- EIN
- 77-0441625
- EDGAR entity type
- operating
- Insiders and CEO pay
- CEPHEID on the corporate pages
Offering terms
- Final price
- $2.39 per share (424B1 filed 2000-06-22, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $11,950,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CPHD
- Lead underwriters
- UBS; Prudential Securities
- Syndicate
- Invemed Associates
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CEPHEID, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Cepheid Fuzzy (name and state)
- Business registration: CEPHEID Fuzzy (name and state)
- Business registration: Cepheid Inc. Fuzzy (name and state)
- Business registration: CEPHEID INC. Fuzzy (name and state)
- Business registration: CEPHEID INC. Fuzzy (name and state)
- Business registration: CEPHEID, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: CEPHEID EXACT (EIN (EXACT))
- Federal award recipient: CEPHEID Fuzzy (name and state)
- Lobbying client: CEPHEID Fuzzy (name and state)
- Lobbying client: CEPHEID Fuzzy (name and state)
- SEC filer: CEPHEID EXACT (CIK (EXACT))
- Person page: Dean O Morton Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-04-07 | S-1 | S-1 (registration) | CEPHEID | 0000891618-00-002048 ↗ |
| 2000-05-18 | S-1/A | S-1/A (amendment) | CEPHEID | 0000891618-00-002962 ↗ |
| 2000-06-07 | S-1/A | S-1/A (amendment) | CEPHEID | 0000891618-00-003208 ↗ |
| 2000-06-08 | S-1/A | S-1/A (amendment) | CEPHEID | 0000891618-00-003234 ↗ |
| 2000-06-13 | S-1/A | S-1/A (amendment) | CEPHEID | 0000891618-00-003321 ↗ |
| 2000-06-21 | S-1/A | S-1/A (amendment) | CEPHEID | 0000891618-00-003454 ↗ |
| 2000-06-22 | 424B1 | 424B1 (final prospectus) | CEPHEID | 0000891618-00-003483 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-06-21 | S-1/A | registration statement | $2.39 | 5,000,000 | $11,950,000 | Nasdaq CPHD | 3 | primary document; price line, shares headline, proceeds computed, cover names 3 | document ↗ | |
| 2000-06-22 | 424B1 | final prospectus | $2.39 | 5,000,000 | $11,950,000 | Nasdaq CPHD | 3 | primary document; price line, shares headline, proceeds computed, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Brown Thomas D | Director | 45 | 2006–2016 | ||
| GUTSHALL THOMAS L | Director | 95 | 2006–2016 | ||
| BISHOP JOHN L | Director,Officer | CEO; Chairman of the Board and CEO | 75 | 2006–2016 | |
| EASTON ROBERT J | Director | 50 | 2006–2016 | ||
| Enns Russell | Officer | Sr. VP, Regulatory; SVP, Chief Regulatory Ofr | 31 | 2006–2013 | |
| KEPNER CRISTINA | Director | 51 | 2006–2016 | ||
| Koska Robert | Officer | Sr VP, Sales and Mktg; SVP US Sales Operations; SVP, Worldwide Sales & Mktg; SVP WW Commercial Ops | 14 | 2006–2010 | |
| McMillan William | Officer; Other | SVP, Development | 2 | 2006 | |
| MORTON DEAN O | Director | 27 | 2006–2015 | person page Fuzzy | |
| MROZ MITCHELL D | Director | 12 | 2006–2011 | ||
| RENTON HOLLINGS | Director | 26 | 2006–2016 | ||
| Reyes Humberto | Officer | Executive VP, COO; Executive VP, Operations; Exec. VP, Operations; Sr. Vice President, Operations | 27 | 2006–2013 | |
| SLUIS JOHN R | Officer | Senior VP, Finance & CFO; SVP, Finance and CFO | 3 | 2006–2007 | |
| SMITH JOSEPH H | Officer | EVP, Bus Dev and GC; EVP, Bus Dev and Gen Counsel; Senior VP, Legal/Business Dev; Sr. VP, General Counsel; SVP, Bus Dev and GC | 74 | 2006–2015 | |
| PERSING DAVID H | Director,Officer | EVP, Chief Med/Tech Officer; Exec VP,Chief Med/Tech Officer | 92 | 2007–2016 | |
| Dailey Peter J | Officer | SVP, Research and Development | 11 | 2008–2010 | |
| Miller Andrew | Officer | CFO; EVP, CFO; SVP, CFO | 67 | 2008–2015 | |
| King Laurie | Officer | Sr. VP, Human Resources | 7 | 2008–2010 | |
| ARNOLD NICOLAAS | Officer | EVP, Worldwide Comm'l Ops | 19 | 2009–2012 | |
| FLOM KERRY | Officer | EVP, Regulatory Affairs; SVP Clinical Affairs & Reg Sub; SVP Clinical & Regulatory | 46 | 2010–2015 | |
| STEELE GLENN JR MD PHD | Director | 31 | 2011–2016 | ||
| Jacon Philippe | Officer | EVP, Emerging Markets; EVP Internat'l CommercialOps | 5 | 2013–2014 | |
| KOCMOND WARREN C JR | Officer | EVP & Chief Operating Officer; EVP, Global Operations; President & COO | 39 | 2013–2016 | |
| Post Jim | Officer | EVP, NA Commercial Operations | 3 | 2013–2014 | |
| Fitzgerald Mike | Officer | EVP, Global Human Resources | 49 | 2014–2016 | |
| Farrell Peter V. | Officer | EVP, Int'l Commercial Ops; EVP, Worldwide Commercial Ops | 21 | 2014–2016 | |
| Madden Dan | Officer | Acting Chief Financial Officer; EVP, Chief Financial Officer | 19 | 2015–2016 | |
| Daskal Ilan | Officer | EVP, Chief Financial Officer | 2 | 2015 | |
| Paterson Wayne | Director | 4 | 2015–2016 | ||
| Campbell Scott A. | Officer | Corporate VP & CRO; VP, Clinical Affairs & CRO | 20 | 2015–2016 | |
| Murray Bill | Officer | EVP, General Counsel | 15 | 2016 | |
| Haugen Marc | Officer | EVP, Global Ops & Engineering | 4 | 2016 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CEPHEID, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| SEC filer | CEPHEID | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Cepheid | State business registries | name and state | |
| Business registration | CEPHEID | State business registries | name and state | |
| Business registration | Cepheid Inc. | State business registries | name and state | |
| Business registration | CEPHEID INC. | State business registries | name and state | |
| Business registration | CEPHEID INC. | State business registries | name and state | |
| Business registration | CEPHEID, INC. | State business registries | name and state | |
| Form 5500 plan sponsor | CEPHEID | EIN (EXACT) | ||
| Federal award recipient | CEPHEID | Federal spending (USAspending) | name and state | |
| Lobbying client | CEPHEID | Federal lobbying (LDA) | name and state | |
| Lobbying client | CEPHEID | Federal lobbying (LDA) | name and state | |
| Person page | Dean O Morton | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, CA first:
- NGEN, INC. CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
- Bionano Genomics, Inc. CA
- AutoGenomics, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology